Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.63 |
| ▸ | IDO1 | P14902 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | DAO | P14920 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610002 | 0.87 | TAAR1 (0.59) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL8096473 | 0.85 | TAAR1 (0.74) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL29596752 | 0.85 | TAAR1 (0.74) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL1609608 | 0.85 | TAAR1 (0.57) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL1610915 | 0.84 | TAAR1 (0.55) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL1610691 | 0.84 | TAAR1 (0.55) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL1610035 | 0.84 | TAAR1 (0.55) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL296418 | 0.81 | — | — | |
| SCHEMBL8092500 | 0.81 | TAAR1 (0.68) | TAAR1IDO1HRH3ACHEDAO | |
| SCHEMBL8099771 | 0.81 | TAAR1 (0.68) | TAAR1IDO1HRH3ACHEDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-111386331-A | Ester compound, lubricating oil composition containing same, and method for producing same | 埃克森美孚化学专利公司 | 2020-07-07 | — | — | CN | claimed |
| WO-2019067061-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| EP-2091945-B1 | NOVEL INHIBITORS OF GLUTAMINYL CYCLASE | PROBIODRUG AG (DE) | 2014-01-15 | — | — | EP | claimed |
| EP-2114118-A1 | SAFEGUARDING SEED SAFETY OF TREATED SEEDS | Bayer CropScience AG (DE) | 2009-11-11 | — | — | EP | claimed |
| EP-2107871-A2 | INSECTICIDAL ACTIVE INGREDIENT COMBINATIONS (FORMONONETINS + INSECTICIDES) | Bayer CropScience AG (DE) | 2009-10-14 | — | — | EP | claimed |
| WO-2009012909-A2 | INSECTICIDAL ACTIVE SUBSTANCE COMBINATIONS (GENESTEIN + INSECTICIDES) | BAYER CROPSCIENCE AG (DE) | 2009-01-29 | — | — | WO | claimed |
| WO-2008064778-A2 | INSECTICIDAL ACTIVE INGREDIENT COMBINATIONS (FORMONONETINS + INSECTICIDES) | BAYER CROPSCIENCE AG (DE) | 2008-06-05 | — | — | WO | claimed |
| EP-1876897-A2 | ACTIVE SUBSTANCE COMBINATIONS | Bayer CropScience AG (DE) | 2008-01-16 | — | — | EP | claimed |
| WO-2006114212-A2 | COMBINATIONS OF PESTICIDAL ACTIVE SUBSTANCE COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2006-11-02 | — | — | WO | claimed |
| US-6730683-B2 | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses | SMITHKLINE BEECHAM CORPORATION | 2004-05-04 | — | — | US | claimed |
| US-6060453-A | Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose | GREENWICH PHARMACEUTICALS INCORPORATED (US) | 2000-05-09 | — | — | US | claimed |
| US-5767277-A | REDUCING AGENT FOR A CARBONYL COMPOUND TO PRODUCE A 1,3-SYN-DIOL COMPOUND | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| US-5663348-A | REDUCTION OF DIKETONE WITH AMINOALKOXYBORANE COMPLEX TO FORM DIALCOHOL ESTER COMPOUND | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1997-09-02 | — | — | US | claimed |
| EP-0221414-A1 | Antihypertensive thieno-isoxazoles and -pyrazoles, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1987-05-13 | — | — | EP | claimed |
| US-4648898-A | DIAMINO-DIFLUOROMETHYLTHIOTRIAZINES | SHIONOGI & CO., LTD. (JP) | 1987-03-10 | — | — | US | claimed |
| US-4338330-A | HYPOTENSIVE AGENTS | CONTINENTAL PHARMA (BE) | 1982-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | TAAR1 1228/4885IDO1 4579/4885HRH3 3865/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | TAAR1 1228/4885IDO1 4579/4885HRH3 3865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.